|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 361 - 378 of 378 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
PL
|
Resepti
|
Cuvitru 200 mg-ml injektioneste, liuos SPC 2024-01-18
|
|
|
European Medicines Agency's website: Cyanokit - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Cyclogest 400 mg emätinpuikko SPC 2021-09-13
|
PL
|
Resepti
|
Cyclophosphamide Accord 200 mg-ml injektio-infuusiokonsentraatti, liuosta varten SPC 2024-06-19
|
PL
|
Resepti
|
Cyklokapron 500 mg tabletti, kalvopäällysteinen SPC 2024-03-27
|
|
|
European Medicines Agency's website: Cymbalta - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Cymevene 500 mg kuiva-aine välikonsentraatiksi infuusionestettä varten, liuos SPC 2023-03-21
|
PL
|
Resepti
|
Cypretyl 2mg 35 mikrog tabletti päällystetty SPC 2023-06-07
|
|
|
European Medicines Agency's website: Cyramza - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Cystadane - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Cystadrops - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Cystagon - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Cytarabin Fresenius Kabi 100 mg-ml injektio-infuusioneste, liuos SPC 2013-06-10
|
PL
|
Resepti
|
Cytarabine Accord 100 mg-ml injektio-infuusioneste, liuos SPC 2022-02-08
|
PL
|
Resepti
|
Cytarabine Accord Healthcare 20 mg-ml injektio-infuusioneste, liuos SPC 2024-04-27
|
PL
|
Resepti
|
Cytarabine Stada 20 mg-ml injektioneste, liuos, 100 mg-ml infuusiokonsentraatti, liuosta varten SPC 2024-10-03
|
PL
|
Resepti
|
Cytarabine Stada 20 mg-ml injektioneste, liuos, 100 mg-ml infuusiokonsentraatti, liuosta varten SPC 2024-10-03
|
PL
|
Resepti
|
Cytotec 0,2 mg tabletti SPC 2020-09-14
|
|
| |